中国全科医学Issue(15)：1784-1786,3.DOI:10.3969/j.issn.1007-9572.2014.15.026
亚急性支架内血栓形成后再次应用盐酸替罗非班致极重度血小板减少一例报道
Very Severe Thrombocytopenia Induced by Tirofiban Application Again after Subacute Stent Thrombosis:One Case Re-port
刘艳军 1李海涛 1刁增利 1闫杰 1王志军 1葛庆锋 1刘培光1
作者信息
- 1. 063000 河北省唐山市，河北联合大学附属医院心内科
- 折叠
摘要
Abstract
Acute coronary syndrome(ACS)is one of the most common cardiology intensive diseases. The percutaneous coronary intervention(PCI),especially the emergency or elective PCI is an important treatment. The application of anti - platelet aggregation drugs before and after the treatment is very important,but the incidence of thrombocytopenia( GIT)induced by platelet glycoprotein Ⅱb/ Ⅲa receptor antagonist(for instance,tirofiban)can increase significantly. This article reports a case of PCI patients had no thrombocytopenia after the first application of tirofiban,but the tirofiban lead to severe thrombocytopenia after the application of tirofiban again after the second PCI because of subacute stent thrombosis. The study of this case and other litera-tures from other countries indicate that close attention should be paid to tirofiban - induced thrombocytopenia.关键词
血栓形成/盐酸替罗非班/血小板减少/血小板膜糖蛋白类/经皮冠状动脉介入术Key words
Thrombosis/Tirofiban hydrochloride/Thrombocytopenia/Platelet membrane glycoproteins/Percutane-ous coronary intervention分类
医药卫生引用本文复制引用
刘艳军,李海涛,刁增利,闫杰,王志军,葛庆锋,刘培光..亚急性支架内血栓形成后再次应用盐酸替罗非班致极重度血小板减少一例报道[J].中国全科医学,2014,(15):1784-1786,3.
